Key Takeaways
- 13% revenue growth, but volumes fell: Q2 FY27 revenue grew 13% YoY, driven entirely by price, mix and forex (+18.3%), while volumes declined 5.1%.
- NAFTA and LATAM delivered standout quarters: NAFTA revenue grew ~30% YoY with significantly better margins; LATAM agrochemical revenue jumped over 80% YoY.
- Europe, the largest market, softened on weather: Extended heat and drought in Central and Eastern Europe made distributors cautious on restocking; management calls it temporary.
- Gross margin expanded 140 bps YoY to 35.9%: Better product mix and operating leverage lifted profitability, and the company remains debt-free with ₹846 crores in cash.
- What to watch next quarter: Whether Europe volumes recover as weather normalizes, whether the H2 margin uptick toward 20% materializes, and whether volume growth turns positive after two quarters of decline.
Volume Degrowth: The Quarter's Central Tension
- Price and mix masked volume weakness: Realization and forex gains contributed 18.3% to the topline, fully offsetting a 5.1% YoY volume decline in Q2 and a 3.5% decline in H1.
- H1 degrowth called abnormal: Management stated H1 volume degrowth was not normal and expects movement toward normality in H2, with consumption seasonally stronger in Q4 and Q3.
- Inventories rose 35% YoY but not at distributors: The inventory build sits on Sharda's books, not in the channel; distributors are not building inventory, which management frames as a positive for future restocking.
- Long-term volume thesis intact: Management does not foresee volumes decreasing due to AI, laser weeding or precision delivery technologies; world population and food consumption growth underpin the volume outlook.
Regional Divergence: NAFTA and LATAM Surge While Europe Pauses
- NAFTA delivered broad strength: Revenue grew ~30% YoY with positive volume growth and significantly better margins, driven by good demand and tighter product availability that gave better pricing possibilities.
- NAFTA margin sustainability: Management feels the NAFTA margin improvement is sustainable, driven by good demand and lesser availability that is giving better pricing possibilities.
- LATAM agrochemicals surged over 80% YoY: Realization growth was better in LATAM and NAFTA compared to Europe, with margins improving maybe because of good product availability at Sharda.
- Europe moderated on weather, not demand: Extended heat and drought in parts of Central and Eastern Europe caused distributors to take a cautious approach to restocking; management views this as temporary and expects the region to do well in H2, its seasonally stronger period.
- Europe profitability outlook: When asked if European business will jump back to original profitability, management said "it is likely to improve." European margins are expected to either stay or improve from current levels.
Bubna: "We see this as a temporary weather-led impact rather than any change in underlying demand. Our registration portfolio and customer relationship in Europe remains strong."
Non-Agrochemical: A Sudden 68% Surge, With a Margin Caveat
- Conveyor belts drove the spike: Non-agrochemical business grew 68% YoY to ₹212 crores, mainly from conveyor belts and rubber belts used for transportation and material handling.
- Demand surge was catch-up buying: Customers who had been waiting for international market uncertainties and transportation problems to improve suddenly found themselves short of stocks and began buying at a faster speed.
- Margins declined despite strong revenue: The segment delivered one of its best performances but margins fell, driven by higher transportation costs in conveyor belts, which form an important part of total cost.
Margins: Expansion Underway, H2 Uptick Expected
- Gross margin expanded 140 bps YoY to 35.9%: H1 gross margin reached 36.3%, up 130 bps YoY, supported by better product mix and operating leverage.
- EBITDA grew 18% YoY to ₹164 crores: EBITDA margin improved 70 bps YoY to 15.6% in Q2; H1 EBITDA grew 22% YoY with margin up 140 bps to 16.1%.
- QoQ gross margin dipped ~1%: The sequential decline from the June quarter was noted; management expects H2 gross margins to hold or go up.
- H2 margin trajectory points higher: Management expects gross margins to hold or go up in H2 FY27, and when asked if H2 EBITDA margins will be upwards of 20% assuming the lower end of the 18% full-year guidance, responded "Yes, it can be."
- Depreciation as a leading indicator: Higher amortization over the last two quarters will continue in H2; this is linked to new products capitalized which will give higher revenue in the future.
The Registration Moat: Unpredictable, Expensive, and Hard to Replicate
- Total registrations reached 3,044 with 946 in pipeline: Over the last 12 months, registrations increased by ~50 while the pipeline dropped by ~120 as some in-process registrations were discontinued and new ones added; no registrations were withdrawn.
- US registration costs blew past expectations: Increased capex in H1 was partly driven by data compensation payments for US registrations, where negotiations went to arbitration and the output came much higher than expected. Management calls these costs "totally unpredictable."
- Registration process is inherently uncertain: Government authorities come out with new requirements at the last moment, approval processes get delayed, and costs can change suddenly; this has been the experience for 25 years.
- The moat is the pain: Management argues the registration process is so complicated, uncertain and uninteresting for investors that competitors prefer deploying capital into tangible assets, limiting competitive entry.
- Tariffs are a non-issue for this model: Because every product needs registration and sourcing is restricted to approved sources, customers have little choice; all tariff increases are easily passed on.
Bubna: "Sir, I have said in every conference call that the process of registration is absolutely unpredictable. And the things change at the last moment, the government authorities come out with new requirements at the last moment and the approval process also gets delayed because the authorities are not able to meet so frequently and many things which are totally beyond anybody's guesswork or planning. And this is what we are facing for the last 25 years."
Pricing, B2C and the Long-Term Bets
- Pricing is improving, but slowly: Management acknowledged pricing is improving but the speed of improvement is still not as per expectation; prices remain far down compared to pre-COVID days but are not impacting general business significantly.
- Product lifecycle dictates pricing power: When a product is freshly off-patent, margins and prices are very good and competition is limited; as products become old and commoditized, prices decline.
- B2C scale-up will be gradual: The company is making attempts to increase B2C share and seeing good results across several geographies, but scale-up will not be fast because B2C requires more manpower, smaller quantities and well-spread geographies versus B2B.
- Bio-products presence increasing: The company is increasing its presence in bio-chem products, though management noted the total biocides market is much smaller than agrochemicals and agrochemical growth is expected to be faster.
- China supply and shipping: Product availability in China is good and prices are fairly competitive; Red Sea and Strait of Hormuz disruptions are not affecting performance significantly, though goods take extra time and freight costs are increasing.
Bubna: "It is improving. The speed of improvement is still not as per our expectation, but it is improving. It is still far down compared to the pre-COVID days, but still, it is not impacting the general business so much."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | 10% to 15% YoY | FY27 |
| EBITDA margin | 18% to 20% | FY27 |
| H2 EBITDA margin | Upwards of 20% (if lower end of full-year guidance holds) | H2 FY27 |
| Capex for registrations | ₹550 crores to ₹600 crores | FY27 |
| Europe recovery | Region expected to do well; registration portfolio and customer relationships remain strong | H2 FY27 (seasonally stronger period) |
| Volume recovery | Movement toward normality expected; uptick in demand | H2 FY27 and FY28 |
| Gross margin trajectory | Expected to hold or go up | H2 FY27 |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue | ₹1,052 cr, +13% YoY |
| Agrochemical revenue | ₹840 cr, +5% YoY |
| Non-agrochemical revenue | ₹212 cr, +68% YoY |
| Gross margin | 35.9%, expanded ~140 bps YoY from 34.5% |
| EBITDA | ₹164 cr, +18% YoY |
| EBITDA margin | 15.6%, up 70 bps YoY from 15% |
| PAT | ₹92 cr, +23% YoY |
| PBT prior to forex | ₹108 cr, +17% YoY on a like-to-like basis |
| Forex impact | Loss of ₹0.4 cr, vs loss of ₹6.1 cr in Q2 FY26 |
| Revenue growth bridge: price, forex, mix | +18.3%, volume degrowth of -5.1% |
| FY27 revenue growth guidance | 10% to 15% |
| FY27 EBITDA margin guidance | 18% to 20%, supported by better product mix and operating leverage in H2 |
| FY27 planned capex for registrations | ₹550 cr to ₹600 cr |
| Total product registrations | 3,044 as on 30 Sep 2026 |
| Registration applications in pipeline | 946 as on 30 Sep 2026 |
| Cash and bank liquid investments | ₹846 cr as on 30 Sep 2026 |
| Working capital days | 70 days, improved by 28 days vs Mar 2026 |
| ROCE | 25.9% |
| ROE | 20.1% |
| NAFTA region revenue growth | ~30% YoY, with significantly better margins |
| LATAM agrochemical revenue growth | Over 80% YoY |
| Gross margin by geography: Europe | 41% |
| Gross margin by geography: NAFTA | ~40% |
| Gross margin by geography: LATAM | 14% |
| Gross margin by geography: Rest of World | 31% |
| H1 FY27 capex spent on registrations | ₹419 cr |
| Depreciation and amortization expense | ~₹100 cr in Q2 FY27, vs ₹70–75 cr in Q2 FY26 |